Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasms by Site 2Neoplasms 2Multiple Myeloma 2Glioblastoma 2Digestive System Neoplasms 2Digestive System Diseases 2Thrombocythemia, Essential 1Sarcoma 1Rectal Diseases 1Primary Myelofibrosis 1Polycythemia Vera 1Pancreatic Diseases 1Oligodendroglioma 1Neoplasms, Plasma Cell 1Leukemia, Myeloid, Acute 1Intestinal Neoplasms 1Intestinal Diseases 1Gliosarcoma 1Glioma 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Endocrine System Diseases 1Endocrine Gland Neoplasms 1Colorectal Neoplasms 1Colonic Diseases 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Renal Cell 1Bone Neoplasms 1

Interventions

fludarabine phosphate 5Cyclophosphamide 4Whole-Body Irradiation 3Cyclosporine 311-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3fludarabine 2Stem Cell Transplantation 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Methylprednisolone 2Hydroxyurea 2Busulfan 2Antilymphocyte Serum 2ruxolitinib 1nelarabine 1fresolimumab 1arsenous acid 1Watchful Waiting 1Thiotepa 1Tetradecanoylphorbol Acetate 1Surveys and Questionnaires 1RG7388 1Phlebotomy 1Oxycodone 1Observation 1Nivolumab 1N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 1Mycophenolic Acid 1Moxifloxacin 1Morphine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Polycythemia Vera × Ascorbic Acid × Clear all
NCT01014546 2022-07-22

Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis

Roswell Park Cancer Institute

Phase 1 Terminated
5 enrolled
Myeloid

Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡